Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

Michael O'Riordan

December 11, 2025

News Daily News

What’s the Damage With Long COVID? Advanced Imaging Reveals Clues

Caitlin E. Cox

May 27, 2025

News Daily News

US Cardiologists’ Pay, Productivity Held Steady in 2022: MedAxiom Survey

Caitlin E. Cox

October 16, 2023

News Conference News EACTS 2022

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

Shelley Wood

October 12, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Daily News

Papers Probe Temporal Link Between COVID-19 Vaccines and Myocarditis

Michael O'Riordan

June 17, 2021

News Daily News

CMR Picks Up Pericardial Inflammation in Student Athletes With COVID-19

Michael O'Riordan

November 06, 2020

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

News Daily News

CMR May Help Evaluate Nonculprit Lesions in STEMI Patients

Todd Neale

September 19, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead

August 22, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries

May 02, 2016

News Daily News

Review: Some Cardiac MRI Findings Help Risk-Stratify CAD Patients

January 29, 2014

Advertisement

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

What’s the Damage With Long COVID? Advanced Imaging Reveals Clues

US Cardiologists’ Pay, Productivity Held Steady in 2022: MedAxiom Survey

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Papers Probe Temporal Link Between COVID-19 Vaccines and Myocarditis

CMR Picks Up Pericardial Inflammation in Student Athletes With COVID-19

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

CMR May Help Evaluate Nonculprit Lesions in STEMI Patients

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries

Review: Some Cardiac MRI Findings Help Risk-Stratify CAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content